Physician profile
Ina Silva
NPI 1194274514
$538.77
in general payments reported to CMS, 2019-2025
16 companies · $122 in 2025
The $122 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $237 · 2022: $11.87 · 2024: $168 · 2025: $122.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $290.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $290.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $181.47 | 2021-2024 | |
| Medtronic, INC. | $79.09 | 2025 | Stealthstation S8 Platform, Strata |
| Vyne Pharmaceuticals INC. | $52.27 | 2021 | |
| Leo Pharma INC. | $28.22 | 2021 | |
| Bioventus LLC | $27.94 | 2024 | |
| Olympus America INC. | $22.69 | 2025 | Olympus |
| Abbott Laboratories | $20.33 | 2025 | Penta |
| Mayne Pharma Commercial LLC | $15.74 | 2021 | |
| Incyte Corporation | $14.72 | 2021 | |
| Genzyme Corporation | $14.67 | 2021 | |
| Lilly USA, LLC | $14.62 | 2021 | |
| Pfizer INC. | $14.30 | 2021 | |
| Amgen INC. | $14.07 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $13.52 | 2021 | |
| Epi Health, LLC | $13.25 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Si-Bone, INC. | $11.87 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ina Silva listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.